PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment

Ítems similars

• Risk stratification tools in prostate cancer, where do we stand?
  per: Clinckaert, Andries, et al.
  Publicat: (2021)
• No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
  per: Karolina Cyll, et al.
  Publicat: (2022-04-01)
• Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity
  per: Algotar, A. M., et al.
  Publicat: (2012)
• Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
  per: Devlies, Wout, et al.
  Publicat: (2021)
• MRI for managing intermediate & low risk prostate cancer
  per: Padhani, Anwar R
  Publicat: (2014)